Skip to content
Institutional Investor growth late-stage Series B Est. 2016

Bio Capital Impact Fund

Private equity investment firm

📍 Melbourne, Australia

About This Fund

Bio Capital Impact Fund is a private equity investment firm. They offer private equity as growth capital to the biotech, med-tech, and agri-tech sectors. Geographies operating include Australia, Asia, Europe, and North America.

Investment Focus

Sectors
health biotech agricultural biotech industrial biotech precision medicine infectious diseases healthspan agribiotech
Stages
growth late-stage Series B
Check Size $6M (based on known deal)
Geography
Global

What They Look For

geography-agnostic, innovative disruptive technologies with measurable impact, high growth potential, later-stage companies

Preparing to pitch Bio Capital Impact Fund?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →